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Introduction 
Insomnia is the most common sleep disorder encountered. It may be 
defined as a subjective complain of impairment in either the duration 
depth or restorative qualities of sleep. Patients suffering from insomnia 
may report difficulties in falling asleep, difficulties in maintaining sleep 
or early awakenings. 
The benzodiazepines constitute present day drug therapy directed 
towards the management of this condition, as their safety and 
effectiveness are better established than those of other classes of drugs. 
However after a long period of dominance in the management of 
insomnia, benzodiazepines have come under critical review. The factors 
spurring such criticism include the facts that the use of these drugs is 
aimed purely at symptomatic relief and not directed towards treating the 
actual condition causing insomnia. Moreover long-term use of such drugs 
has been implicated in problems related to drug dependance. This has 
led to the development of a new approach to the management of insomnia 
involving a diagnostic assessment directed at uncovering the underlying 
factors predisposing to insomnia and whenever possible their immediate 
treatment, together with counselling the patient on sleep hygiene. 
Studies were carried out to: 
a) investigate trends of insomnia amongst the Maltese population 
b) assess the effectiveness of patient counselling on the management 
of insomnia 
Methodology 
Study 1: The aim of this study was directed at investigating the 
percentage incidence of insomnia over the Maltese population. Therefore, 
a number of subjects was randomly selected from the local 1990 Telephone 
Directory Supplement. Of the 200 subjects originally contacted, 58 
declined to cooperate. Questioning of the compliant revealed 46 subjects 
(32.4%) to be suffering from insomnia. A data sheet containing the 
relevant information was drawn up, and filled in for each individual, 
following careful questioning. These included: 
a) age 
b) sex 
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c) average number of hours slept per day 
d) nature of sleep disorder: i) difficulty in falling asleep 
iD difficulty in maintaining 
sleep 
iii) both 
e) any seasonal trends 
f) whether any physician was ever consulted 
g) any medicament taken 
h) any advice given by the pharmacist 
Study 2: This study was directed towards the effectiveness of patient 
education, with respect to sleep hygiene. Of the original 46 individuals 
found to be suffering from insomnia, 19 were not undergoing drug therapy 
directed towards treating insomnia, and were therefore considered 
eligible for inclusion. Of these, 14 accepted participation. 
The protocol adopted for this trial involved the following four stages: 
Stage 1: 
A ten day sleep diary was taken for each subject, in which the patients 
were asked to record the number of hours slept per night. In this way, it 
was possible to calculate the mean number of hours slept per individual, 
per night. 
Stage 2: 
The aim of his study was to determine the underlying cause of the 
patient's insomnia. A list of possible factors predisposing to the condition 
was drawn up, and filled in, for each subject. Based on the results, it was 
possible to individualise sleep hygienc thcrapy. 
Stage 3: 
Twelve patients passed into this third stage of therapy. These were 
individually advised on sleep hygiene after cause was taken into 
consideration. 
Stage 4: 
A ten day sleep diary was compiled again, and the results compared to 
the results in Stage 1. In this way, the effectiveness of therapy could be 
assessed. 
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Study 2 
Table 1: Probably underlying causes of Insomnia in participants 
considered in this study 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Source 
Occupational 
Occupational 
Untreated pain 
Untreated pathological condition 
Pharmacological 
Anxiety 
Anxiety 
Anxiety 
Anxiety 
Depression 
Depression 
Adjustment disorder 
Table 2: Mean number of hours slept per subject per night, before and after 
therapy 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Mean No. of hours 
slept before 
4.8 
5.2 
3.7 
4.5 
3.3 
5.0 
5.1 
5.1 
4.9 
2.9 
5.2 
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Mean No. of hours 
slept after 
6.7 
5.9 
7.0 
6.6 
5.1 
5.0 
4.9 
6.2 
5.3 
3.4 
5.1 
Discussion 
Study 1: The results obtained in the first study with regards to the 
incidence of insomnia and trends related to sex/age can be closely 
correlated to a similar epidemiological study carried out in the U.s.A. 
(Mellinger, Balter and Uhlenhuth, 1985). The latter revealed a 
percentage incidence of insomnia ranging from 13 - 40% of the adult 
population, prevalence increasing with age and being more common in 
women. These results compare well with results obtained in this local 
study (Diagrams 1 - 3). 
63% of the gross population of insomniacs were undergoing drug therapy. 
However, only 52% of the original population had ever sought medical 
counsel, and these, invariably placed on hypnotic medication, at one 
stage or another. The resulting discrepancy [(63 - 52)% = 11 %)] repres.erits 
the portion of individuals on drug therapy without the necessary legal 
prescription. It is therefore evident that hypnotics, when used in 
alleviating insomnia are very much liable to misuse and abuse. It is in 
this fie~d that the pharmacist can play a prominent role, proposing 
relevant advice and/or refusing dispensing of the said medication 
without the required medical prescription. Sadly, the role of the 
pharmacist is underestimated in this context; this is reflected in an 
opinion poll presented to. those subjects (63%) undergoing drug therapy. 
Of these, only 31 % considered the pharmacist to be in an ideal position as 
to educate the public in this regard. 
Study 2: 9 of the 12 (75%) participants showed signs of improvement, 
following therapy. This was reflected in an increase in the mean number 
of hours slept, registered through the ten day sleep diary. This 
improvement cannot be taken to represent total success, since many of the 
patients illustrated only marginal improvement in their sleep pattern. 
Considerable succes~ was however achieved jn patients 1,3,4,5,8 and 12, 
reflecting a success rate of 50% over the original 12 participants. 
The one important limitation encountered during this study was the 
insufficient personnel-patient contact. Studies of this nature are 
normally carried out in sleep laboratories, the subjects being constantly 
monitored. Measurements are then carried out by the residing personnel. 
In this way, chances of error are minimised. In this study, the 
participant himself was required to keep record of the number of hours 
slept. Under such conditions, errors incurred as a consequence of inaccurate 
time-keeping are increased. 
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Conclusion 
From the results, it appears evident that insomnia is a condition which is 
both overlooked and underestimated. The insomniac tends to regard the 
physician simply as the provider of the drug, advice beyond drug 
therapy severely undermined. This has contributed to the increase in 
benzodiazepine consumption, and the overprescription of such drugs. The 
pharmacist, and physician alike should play a more active role when 
consulted by the insomniac, considering patient history, listening to the 
patient's worries, making necessary examinations and investigations, 
reassuring the patient and offering treatment when required. 
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